These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32219686)

  • 21. The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0.
    Cui Y; Liu X; Li S; Wang H; Xiang Y; Zhang Y; Song M; Geng J; Liu Z; Teng H; Zhu X; Cai Y; Li Y; Wang W
    Clin Transl Oncol; 2024 Apr; 26(4):1012-1021. PubMed ID: 38051436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.
    Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY
    PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased lymph node yield indicates improved survival in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Wang Y; Zhou M; Yang J; Sun X; Zou W; Zhang Z; Zhang J; Shen L; Yang L; Zhang Z
    Cancer Med; 2019 Aug; 8(10):4615-4625. PubMed ID: 31250569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical relevance of adjuvant chemotherapy in locally advanced rectal cancer patients achieving near pathological complete response following neoadjuvant chemoradiotherapy: Insights from ypT stage.
    Cai Y; Chen M; Ye F; Liu Z; Luo S; Huang L; Kang L
    Eur J Surg Oncol; 2024 Apr; 50(4):108001. PubMed ID: 38364330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph nodes regression grade is a predictive marker for rectal cancer after neoadjuvant therapy and radical surgery.
    Li J; Yuan J; Liu H; Yin J; Liu S; Du F; Hu J; Li C; Niu X; Lv B; Xing S
    Oncotarget; 2016 Mar; 7(13):16975-84. PubMed ID: 26934651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment MRI-detected extramural venous invasion as a prognostic and predictive biomarker for neoadjuvant chemoradiotherapy in non-metastatic rectal cancer: a propensity score matched analysis.
    Yang SY; Bae H; Seo N; Han K; Han YD; Cho MS; Hur H; Min BS; Kim NK; Lee KY; Lim JS
    Eur Radiol; 2024 Jun; 34(6):3686-3698. PubMed ID: 37994967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of glucocorticoids on the efficacy of neoadjuvant chemoradiotherapy and survival of patients with locally advanced rectal cancer: a retrospective study.
    Huang X; Zheng Z; Zeng B; Xiao H; Zheng H; Lin Z; Song J; Li A; Chi P; Yang Y; Xu B; Zheng R
    BMC Cancer; 2023 Mar; 23(1):238. PubMed ID: 36918865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of Lymph Node Harvest on Prognosis in Locally Advanced Middle-Low Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Lin Z; Li X; Song J; Zheng R; Chen C; Li A; Xu B
    Front Oncol; 2022; 12():816485. PubMed ID: 35242710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 30. Circulating lymphocytes as predictors of sensitivity to preoperative chemoradiotherapy in rectal cancer cases.
    Dou X; Wang RB; Yan HJ; Jiang SM; Meng XJ; Zhu KL; Xu XQ; Mu DB
    Asian Pac J Cancer Prev; 2013; 14(6):3881-5. PubMed ID: 23886201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymph node regression grading of locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    He L; Xiao J; Zheng P; Zhong L; Peng Q
    World J Gastrointest Oncol; 2022 Aug; 14(8):1429-1445. PubMed ID: 36160739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients.
    Li SF; Wei R; Yu GH; Jiang Z
    World J Gastrointest Oncol; 2022 Nov; 14(11):2224-2237. PubMed ID: 36438711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Value of the Distribution of Lymph Node Metastasis in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Chen B; Liu X; Zhang Y; Zhuang J; Peng Y; Wang Y; Wu Y; Li S; Yang Y; Guan G
    Front Surg; 2021; 8():749575. PubMed ID: 34869558
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognostic factors in patients with complete response of the tumour (ypT0) after neoadjuvant chemoradiotherapy and radical resection of rectal cancer.
    Zhang H; Sun G; Zheng K; Lou Z; Gao XH; Meng RG; Furnée EJB; Zhang W
    ANZ J Surg; 2021 Apr; 91(4):E190-E195. PubMed ID: 33559307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Predictive Value of Pre-/Postneoadjuvant Chemoradiotherapy MRI Characteristics for Patient Outcomes in Locally Advanced Rectal Cancer.
    Meng Y; Wan L; Zhang C; Wang C; Ye F; Li S; Zou S; Cheng J; Xu K; Zhou C; Zhang H
    Acad Radiol; 2020 Sep; 27(9):e233-e243. PubMed ID: 31780392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
    Zhang Y; Liu X; Xu M; Chen K; Li S; Guan G
    Sci Rep; 2020 May; 10(1):8017. PubMed ID: 32415197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
    Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
    Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
    Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
    Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.